Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 3/20 | 0.46 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.46 |
| ▸ | CHRM3 | P20309 | 3/20 | 0.46 |
| ▸ | LMNA | P02545 | 3/20 | 0.46 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.46 |
| ▸ | HRH1 | P35367 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | ESR1 | P03372 | 1/20 | 0.46 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.46 |
| ▸ | KCNE1 | P15382 | 1/20 | 0.46 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.46 |
| ▸ | HRH2 | P25021 | 1/20 | 0.46 |
| ▸ | HTR2A | P28223 | 1/20 | 0.46 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.46 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.46 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.46 |
| ▸ | KCNQ1 | P51787 | 1/20 | 0.46 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.46 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.46 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15492087 | 0.88 | LMNA (0.47) | CHRM2CHRM1CHRM3LMNACHRM5 | |
| SCHEMBL11294062 | 0.88 | HRH1 (0.50) | CHRM2CHRM1CHRM3LMNACHRM5 | |
| SCHEMBL6459390 | 0.88 | HRH1 (0.50) | CHRM2CHRM1CHRM3LMNACHRM5 | |
| SCHEMBL580184 | 0.82 | MEN1 (0.47) | CHRM2CHRM1CHRM3LMNACHRM5 | |
| SCHEMBL580170 | 0.82 | MEN1 (0.47) | CHRM2CHRM1CHRM3LMNACHRM5 | |
| Desfesoterodine SCHEMBL29468683 | 0.82 | CHRM3 (0.72) | CHRM2CHRM1CHRM3LMNACHRM5 | |
| Desfesoterodine SCHEMBL816124 | 0.82 | CHRM3 (0.72) | CHRM2CHRM1CHRM3LMNACHRM5 | |
| SCHEMBL580169 | 0.82 | MEN1 (0.47) | CHRM2CHRM1CHRM3LMNACHRM5 | |
| Desfesoterodine SCHEMBL580657 | 0.82 | CHRM3 (0.72) | CHRM2CHRM1CHRM3LMNACHRM5 | |
| Desfesoterodine SCHEMBL209062 | 0.82 | CHRM3 (0.72) | CHRM2CHRM1CHRM3LMNACHRM5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8742140-B2 | Chiral intermediate, process for producing the same and its use in the manufacture of tolterodine, fesoterodine, or the active metabolite thereof | UCB PHARMA GMBH (DE) | 2014-06-03 | — | — | US | disclosed |
| US-8742140-B2 | Chiral intermediate, process for producing the same and its use in the manufacture of tolterodine, fesoterodine, or the active metabolite thereof | UCB PHARMA GMBH (DE) | 2014-06-03 | — | — | US | disclosed |
| EP-2027103-B1 | NEW CHIRAL INTERMEDIATE, PROCESS FOR PRODUCING THE SAME AND ITS USE IN THE MANUFACTURE OF TOLTERODINE, FESOTERODINE, OR THE ACTIVE METABOLITE THEREOF | UCB PHARMA GMBH (DE) | 2014-02-26 | — | — | EP | disclosed |
| US-20110245338-A1 | CHIRAL INTERMEDIATE, PROCESS FOR PRODUCING THE SAME AND ITS USE IN THE MANUFACTURE OF TOLTERODINE, FESOTERODINE, OR THE ACTIVE METABOLITE THEREOF | UCB PHARMA GMBH (DE) | 2011-10-06 | — | — | US | disclosed |
| US-20110245338-A1 | CHIRAL INTERMEDIATE, PROCESS FOR PRODUCING THE SAME AND ITS USE IN THE MANUFACTURE OF TOLTERODINE, FESOTERODINE, OR THE ACTIVE METABOLITE THEREOF | UCB PHARMA GMBH (DE) | 2011-10-06 | — | — | US | disclosed |
| US-7982058-B2 | Chiral intermediate, process for producing the same and its use in the manufacture of tolterodine, fesoterodine, or the active metabolite thereof | UCB PHARMA GMBH (DE) | 2011-07-19 | — | — | US | disclosed |
| US-7982058-B2 | Chiral intermediate, process for producing the same and its use in the manufacture of tolterodine, fesoterodine, or the active metabolite thereof | UCB PHARMA GMBH (DE) | 2011-07-19 | — | — | US | disclosed |
| US-20090192224-A1 | CHIRAL INTERMEDIATE, PROCESS FOR PRODUCING THE SAME AND ITS USE IN THE MANUFACTURE OF TOLTERODINE, FESOTERODINE, OR THE ACTIVE METABOLITE THEREOF | SCHWARZ PHARMA AG (DE) | 2009-07-30 | — | — | US | disclosed |
| US-20090192224-A1 | CHIRAL INTERMEDIATE, PROCESS FOR PRODUCING THE SAME AND ITS USE IN THE MANUFACTURE OF TOLTERODINE, FESOTERODINE, OR THE ACTIVE METABOLITE THEREOF | SCHWARZ PHARMA AG (DE) | 2009-07-30 | — | — | US | disclosed |
| WO-2007144097-A1 | NEW CHIRAL INTERMEDIATE, PROCESS FOR PRODUCING THE SAME AND ITS USE IN THE MANUFACTURE OF TOLTERODINE, FESOTERODINE, OR THE ACTIVE METABOLITE THEREOF | SCHWARZ PHARMA AG (DE) | 2007-12-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090192224-A1 | CHIRAL INTERMEDIATE, PROCESS FOR PRODUCING THE SAME AND ITS USE IN THE MANUFACTURE OF TOLTERODINE, FESOTERODINE, OR THE ACTIVE METABOLITE THEREOF | CYP1B1, NISCH, HSD17B7 | CHRM2 108/4885CHRM1 133/4885CHRM3 107/4885 |
| US-20110245338-A1 | CHIRAL INTERMEDIATE, PROCESS FOR PRODUCING THE SAME AND ITS USE IN THE MANUFACTURE OF TOLTERODINE, FESOTERODINE, OR THE ACTIVE METABOLITE THEREOF | CYP1B1, NISCH, HSD17B7 | CHRM2 108/4885CHRM1 133/4885CHRM3 107/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.